Skip to content
value.today
Total raised
$74 M
10 rounds on record
Latest round
$4 M
Sep 2020
First round on record
Sep 2011
Today
Private
No later event on record

Funding rounds

10 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Clinipace Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2020$4 MNo. 10$2 to $10 million

Clinipace Inc: Raise no. 10, Sep 2020

Investors in this round

10 investors had bought by the notice of Oct 6, 2020: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $10 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director
  • Steven List · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.”

Signed by Miranda R. Miller, Attorney-in-fact. Source: SEC Form D, newest notice filed Oct 6, 2020. Read the notice at the SEC.

debt, optionsSEC
Oct 2019$15 MNo. 9$10 to $50 million

Clinipace Inc: Raise no. 9, Oct 2019

Investors in this round

16 investors had bought by the notice of Feb 3, 2020: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • Chris Semple · Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.”

Signed by Miranda R. Miller, Attorney-in-fact. Source: SEC Form D and 1 amendment, newest notice filed Feb 3, 2020. Read the notice at the SEC.

debt, optionsSEC
Jul 2019$4 MNo. 8$2 to $10 million

Clinipace Inc: Raise no. 8, Jul 2019

Investors in this round

13 investors had bought by the notice of Aug 7, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • Chris Semple · Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Aug 7, 2019. Read the notice at the SEC.

equitySEC
Mar 2019$4 MNo. 7$2 to $10 million

Clinipace Inc: Raise no. 7, Mar 2019

Investors in this round

13 investors had bought by the notice of Mar 14, 2019: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • Chris Semple · Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Mar 14, 2019. Read the notice at the SEC.

equitySEC
Aug 2018$6 MNo. 6$2 to $10 million

Clinipace Inc: Raise no. 6, Aug 2018

Investors in this round

13 investors had bought by the notice of Sep 10, 2018: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • Chris Semple · Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Sep 10, 2018. Read the notice at the SEC.

equitySEC
Dec 2017$10 MNo. 5$10 to $50 million

Clinipace Inc: Raise no. 5, Dec 2017

Investors in this round

16 investors had bought by the notice of Dec 19, 2017: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $20 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jason Monteleone · Executive Officer, Director
  • Chris Semple · Director
  • David Fitzgerald · Director
  • Jeremy Mario · Director
  • Jesse Watson · Director
  • Melissa Daniels · Director
  • Steve Skolsky · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Miranda R. Miller, Attorney-in-Fact. Source: SEC Form D, newest notice filed Dec 19, 2017. Read the notice at the SEC.

equitySEC
Jul 2016$4 MNo. 4$2 to $10 million

Clinipace Inc: Raise no. 4, Jul 2016

Investors in this round

10 investors had bought by the notice of Jul 21, 2016: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Mark K. Ubert · Executive Officer
  • Brian K. Carney · Director
  • David K. Fitzgerald · Director
  • Gena K. Reed · Director
  • Jeremy K. Mario · Director
  • Jesse K. Watson · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chris Porter, Secretary. Source: SEC Form D, newest notice filed Jul 21, 2016. Read the notice at the SEC.

equitySEC
Jan 2015$18 MIssued in a merger or acquisition$10 to $50 million

Clinipace Inc: Private sale, Jan 2015

Investors in this round

13 investors had bought by the notice of Jan 15, 2015: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$18 M of $32 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Mark K. Ubert · Executive Officer
  • Brian K. Carney · Director
  • David K. Fitzgerald · Director
  • Gena K. Reed · Director
  • Jeremy K. Mario · Director
  • Jesse K. Watson · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Ubert, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 15, 2015. Read the notice at the SEC.

equitySEC
Jan 2014$3 MNo. 3$2 to $10 million

Clinipace Inc: Raise no. 3, Jan 2014

Investors in this round

1 investor had bought by the notice of Feb 7, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Mark K. Ubert · Executive Officer
  • Brian K. Carney · Director
  • David K. Fitzgerald · Director
  • Gena K. Reed · Director
  • Jeremy K. Mario · Director
  • John K. Crumpler · Director
  • Julia K. Gregory · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher K. Porter, President & Secretary. Source: SEC Form D, newest notice filed Feb 7, 2014. Read the notice at the SEC.

debt, optionsSEC
Oct 2012$9 MNo. 2$2 to $10 million

Clinipace Inc: Raise no. 2, Oct 2012

Investors in this round

3 investors had bought by the notice of Oct 25, 2012: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Brian K. Carney · Director
  • Gena K. Reed · Director
  • Jeremy K. Mario · Director
  • John K. Crumpler · Director
  • Julia K. Gregory · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Byron B. Kirkland, Attorney-in-Fact. Source: SEC Form D, newest notice filed Oct 25, 2012. Read the notice at the SEC.

equity, debt, optionsSEC
Sep 2012$13 MIssued in a merger or acquisition$10 to $50 million

Clinipace Inc: Private sale, Sep 2012

Investors in this round

6 investors had bought by the notice of Sep 17, 2012: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $13 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Gena K. Reed · Director
  • Jeremy K. Mario · Director
  • John K. Crumpler · Director
  • Julia K. Gregory · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Byron B. Kirkland, Attorney-in-Fact. Source: SEC Form D, newest notice filed Sep 17, 2012. Read the notice at the SEC.

debt, optionsSEC
Sep 2011$16 MNo. 1$10 to $50 million

Clinipace Inc: Raise no. 1, Sep 2011

Investors in this round

14 investors had bought by the notice of Oct 4, 2011: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher K. Porter · Executive Officer
  • Jeff L. Williams · Executive Officer, Director
  • Jeremy K. Mario · Director
  • John K. Crumpler · Director
  • Ken K. Lee · Director
  • Melissa K. Daniels · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher K. Porter, Secretary. Source: SEC Form D, newest notice filed Oct 4, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Clinipace Inc chose not to state its revenue in its newest notice of a funding round (Oct 2020).

    SEC Form D · Oct 2020

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2020

That is all the official record says: Clinipace Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Clinipace Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 10 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Clinipace Inc
NameRoleNamed in
Jason MonteleoneExecutive officerOct 2020
Christopher K. PorterExecutive officerJul 2016
Jeff L. WilliamsExecutive officerJul 2016
Mark K. UbertExecutive officerJul 2016
David FitzgeraldDirectorOct 2020
Jason MonteleoneDirectorOct 2020
Jeremy MarioDirectorOct 2020
Jesse WatsonDirectorOct 2020
Melissa DanielsDirectorOct 2020
Steve SkolskyDirectorOct 2020
Steven ListDirectorOct 2020
Chris SempleDirectorFeb 2020
Brian K. CarneyDirectorJul 2016
David K. FitzgeraldDirectorJul 2016
Gena K. ReedDirectorJul 2016
Jeff L. WilliamsDirectorJul 2016
Jeremy K. MarioDirectorJul 2016
Jesse K. WatsonDirectorJul 2016
Ken K. LeeDirectorJul 2016
Melissa K. DanielsDirectorJul 2016
John K. CrumplerDirectorFeb 2014
Julia K. GregoryDirectorFeb 2014